To test this hypothesis , PRRSV negative piglets were injected with a monoclonal Ab2 ( Mab2-5G2 ) and aAb2s that are specific for anti-GP5 antibody , vaccinated with the attenuated PRRSV vaccine CH-1R and then challenged with the highly pathogenic PRRSV HuN4 strain .